Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04632511Not ApplicableActive Not Recruiting

Metabotyping of Overweight and Obese Children

Role: collaborator

NCT06171191Not ApplicableRecruiting

Move ARound And Get Active: an Intervention to Optimize 24-hour Movement Behaviours in Preschoolers

Role: collaborator

NCT05446675Completed

Endoscopic eTEP Versus Open Rives-Stoppa

Role: lead

NCT03319355Not ApplicableCompleted

Multicomponent Therapy for Fibromyalgia

Role: collaborator

All 4 trials loaded